These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 25467593)
41. A DNA vaccine for the prevention of Ebola virus infection. Dery M; Bausch DG Curr Opin Mol Ther; 2008 Jun; 10(3):285-93. PubMed ID: 18535936 [TBL] [Abstract][Full Text] [Related]
44. Ebola drug trial is to start next month. Gulland A BMJ; 2014 Oct; 349():g6436. PubMed ID: 25342503 [No Abstract] [Full Text] [Related]
45. [Ebola: a vaccine on forced accelerated course. Hopes for the ZMapp]. Nau JY Rev Med Suisse; 2014 Sep; 10(441):1682-3. PubMed ID: 25322630 [No Abstract] [Full Text] [Related]
46. Ebola: public-private partnerships. Reperant LA; van de Burgwal LH; Claassen E; Osterhaus AD Science; 2014 Oct; 346(6208):433-4. PubMed ID: 25342793 [No Abstract] [Full Text] [Related]
47. Infectious Disease. Ebola vaccines racing forward at record pace. Cohen J Science; 2014 Sep; 345(6202):1228-9. PubMed ID: 25214582 [No Abstract] [Full Text] [Related]
48. Ebola: a game changer for vaccines, or a scare that will soon be forgotten? Arie S BMJ; 2015 May; 350():h1938. PubMed ID: 25948574 [No Abstract] [Full Text] [Related]
50. How high is too high for the threshold on patent utility? Sklan A Pharm Pat Anal; 2012 Jul; 1(3):237. PubMed ID: 24236834 [No Abstract] [Full Text] [Related]
51. Ebola vaccine yields first hopes of clinical efficacy. Mullard A Nat Rev Drug Discov; 2015 Sep; 14(9):593. PubMed ID: 26323537 [No Abstract] [Full Text] [Related]
52. [Potential vaccine candidates against Ebola and the first vaccine against chikungunya virus infection]. Nau JY Rev Med Suisse; 2014 Aug; 10(439):1570-1. PubMed ID: 25272676 [No Abstract] [Full Text] [Related]
53. Panel rules against Canada on patent terms for pre-TRIPS patents. Elliott R Can HIV AIDS Policy Law Newsl; 2000; 5(2-3):43, 45. PubMed ID: 11833196 [TBL] [Abstract][Full Text] [Related]
54. Canadian High Court upholds Glaxo Wellcome AZT patent. AIDS Policy Law; 2002 Dec; 17(22):3. PubMed ID: 12510642 [No Abstract] [Full Text] [Related]
55. Drug patent protection: how long is long enough? Sibbald B CMAJ; 2001 May; 164(9):1331. PubMed ID: 11341146 [No Abstract] [Full Text] [Related]
56. Ebola vaccine trial falls short of homerun. DeFrancesco L Nat Biotechnol; 2015 Oct; 33(10):1011-2. PubMed ID: 26448067 [No Abstract] [Full Text] [Related]
57. Intellectual property. Balancing innovation and access: patent challenges tip the scales. Higgins MJ; Graham SJ Science; 2009 Oct; 326(5951):370-1. PubMed ID: 19833944 [No Abstract] [Full Text] [Related]
58. Ebola virus epidemic in war-torn eastern DR Congo. Claude KM; Underschultz J; Hawkes MT Lancet; 2018 Oct; 392(10156):1399-1401. PubMed ID: 30297137 [No Abstract] [Full Text] [Related]
59. Canada to change patent law to allow export of cheap drugs. Kondro W Lancet; 2003 Oct; 362(9392):1290. PubMed ID: 14577437 [No Abstract] [Full Text] [Related]
60. The Ebola Vaccine, Iatrogenic Injuries, and Legal Liability. Attaran A; Wilson K PLoS Med; 2015 Dec; 12(12):e1001911. PubMed ID: 26625163 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]